TG THERAPEUTICS INC (TGTX)
US88322Q1085 - Common Stock
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | N/A | N/A | N/A | 399.90M | 110.10M | |||
| Cash Equivalents | 92.93M | 102.30M | 298.90M | 153.60M | 2.50M | |||
| Marketable Securities | 124.58M | 59.40M | 15.90M | 52.00M | 27.80M | |||
| Receivables | 51.09M | 0.00 | 1.40M | N/A | N/A | |||
| Inventories | 39.82M | N/A | N/A | N/A | N/A | |||
| Other Current Assets | 9.52M | 6.60M | 14.80M | 6.30M | 8.70M | |||
| Total Current Assets | 317.94M | 168.30M | 331.00M | 611.70M | 149.20M | |||
| Non-Current Assets | ||||||||
| PPE Net | 9.56M | 10.80M | 11.10M | 11.80M | 11.80M | |||
| Investments And Advances | 0.00 | 12.40M | 35.50M | N/A | N/A | |||
| Goodwill | 799.00K | 800.00K | 800.00K | 800.00K | 800.00K | |||
| Other Non-Current Assets | 1.28M | 1.30M | 1.30M | 1.30M | 1.30M | |||
| Total Non-Current Assets | 11.64M | 25.30M | 48.60M | 13.90M | 13.80M | |||
| TOTAL ASSETS | 329.59M | 193.60M | 379.60M | 625.60M | 163.00M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | N/A | 0.00 | 1.00M | 23.10M | 200.00K | |||
| Accrued Expenses | 13.62M | 10.00M | 11.60M | 10.10M | 5.40M | |||
| Accounts Payable | 38.47M | 42.00M | 51.30M | 37.00M | 30.00M | |||
| Other Current Liabilities | 1.63M | 1.20M | 1.50M | 17.30M | 48.80M | |||
| Total Current Liabilities | 53.72M | 53.20M | 65.40M | 87.60M | 84.40M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 100.12M | 71.10M | 66.80M | 7.70M | 29.00M | |||
| Other Non-Current Liabilities | 15.25M | 10.60M | 10.30M | 11.00M | 11.00M | |||
| Total Non-Current Liabilities | 115.36M | 81.80M | 77.10M | 18.70M | 40.00M | |||
| TOTAL LIABILITIES | 169.09M | 135.00M | 142.50M | 106.30M | 124.40M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -1.51B | -1.53B | -1.33B | -980.60M | -701.20M | |||
| Additional Paid In Capital | 1.67B | 1.59B | 1.57B | 1.50B | 740.00M | |||
| Common Shares | 151.00K | 100.00K | 100.00K | 100.00K | 100.00K | |||
| Treasury Stock | -234.00K | -200.00K | -200.00K | -200.00K | -200.00K | |||
| Other Shareholders' Equity | N/A | N/A | N/A | N/A | N/A | |||
| Shares Outstanding | 151.42M | 146.40M | 143.30M | 140.60M | 109.40M | |||
| Tangible Book Value per Share | 1.05 | 0.39 | 1.65 | 3.69 | 0.35 | |||
| Total Shareholders' Equity | 160.50M | 58.60M | 237.20M | 519.40M | 38.60M | |||
| TOTAL LIABILITIES AND EQUITY | 329.59M | 193.60M | 379.60M | 625.60M | 163.00M | |||
| Statistics | ||||||||
| Debt/Equity | 0.62 | 1.21 | 0.28 | 0.01 | 0.75 | |||
| Current Ratio | 5.92 | 3.16 | 5.06 | 6.98 | 1.77 | |||
| Return On Assets (ROA) | 3.84% | -102.45% | -91.70% | -44.66% | -106.06% | |||
| Return On Equity (ROE) | 7.90% | -338.46% | -146.75% | -53.79% | -447.85% | |||
| Return On Invested Capital (ROIC) | 5.91% | N/A | N/A | N/A | N/A | |||
| Return On Invested Capital Ex Cash (ROICexc) | 27.93% | N/A | N/A | N/A | N/A | |||
| Return On Invested Capital Ex Cash + Goodwill (ROICexcg) | 28.32% | N/A | N/A | N/A | N/A | |||
All data in USD